Webinar something pending, page-31

...... still waiting for .... well anything really to be announced .... the Webinar date perhaps ? What a boring uneventful year Starpharma has had in 2024 thus far - clearly represented by the current share price / market cap of circa $50 million







@Gumnut70 has only posted 3 times this year but in all 3 still claims how great the science supposedly is all the time while supposed partners in the fold are looking under the hood through an NDA and not committing to licensing any of the 3 internal DEP drugs trialed by Starpharma through their phase 2 trials... who to believe given we know the 'partners' have seen a lot more data than us retail plebs have ?


Looks like they disagree at this stage after seeing all the additional data .... perhaps these are the "hard decisions" the new CEO is referencing in her comments in the recent Quarterly Report ? What a disaster if we are now a company back at the drawing board with the Medicxi deal with more "studies"


GLTAH